Asset Details
Do you wish to reserve the book?
Long-term low-dose aspirin promotes laser-induced choroidal neovascularization through suppressing TSP-1 expression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Long-term low-dose aspirin promotes laser-induced choroidal neovascularization through suppressing TSP-1 expression
Do you wish to request the book?
Long-term low-dose aspirin promotes laser-induced choroidal neovascularization through suppressing TSP-1 expression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Long-term low-dose aspirin promotes laser-induced choroidal neovascularization through suppressing TSP-1 expression
2025
Overview
To investigate the impact of low-dose, long-term aspirin use on neovascular age-related macular degeneration (nAMD).
Adult C57BL/6J or Thbs-1
mice were treated with daily aspirin (1.25 mg/kg) for 8 weeks before being subjected to laser-induced choroidal neovascularization (CNV). The animals were left for 7-10 days with continued aspirin use before the eyes were collected for further investigations. Bone marrow-derived macrophages (BMDMs) and primary retinal pigment epithelial (RPE) cells were treated with different concentrations of aspirin (1, 10, 100 μM) for two days before being subjected to LPS+IFNγ for 16 h. The expression of cytokine genes was evaluated by qRT-PCR. The concentrations of thrombospondin-1 (TSP-1) were measured by ELISA.
Aspirin treatment did not affect circulating immune cell profiles in normal mice but significantly increased CD11b
cells in laser-induced CNV mice. The treatment significantly increased the severity of laser-induced CNV and reduced serum levels of TSP-1.
aspirin treatment upregulated
and
, down-regulated
mRNA expression, and reduced TSP-1 production in LPS+IFNγ-treated M1 BMDMs but not RPE cells. Thbs-1
mice developed severe laser-induced CNV, which was not affected by aspirin intervention. nAMD patients had significantly lower serum levels of TSP-1 than healthy controls, although no significant difference was found between nAMD patients with and without aspirin use.
Low-dose long-term aspirin use promoted the severity of laser-induced CNV by down-regulating TSP-1. Lower serum levels of TSP-1 may be a risk factor for nAMD. The long-term ocular safety of aspirin should be validated in prospective cohorts.
Publisher
Frontiers Media S.A
Subject
